Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Malignant Lymphoma

  Free Subscription


26.01.2026

1 Blood
2 BMC Cancer
1 Bone Marrow Transplant
3 Br J Haematol
1 Eur J Immunol
2 Int J Cancer
1 J Am Acad Dermatol
1 J Clin Oncol
1 J Natl Cancer Inst
2 Leuk Lymphoma


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Blood

  1. CHIODIN G, Tatterton DJ, Rock PJ, Del Rio L, et al
    DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and Survival.
    Blood. 2026 Jan 20:blood.2025030049. doi: 10.1182/blood.2025030049.
    PubMed         Abstract available


    BMC Cancer

  2. DAWOOD S, McMillan B, Brown K, Oosthuizen J, et al
    Correction to: Early-stage hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes.
    BMC Cancer. 2026;26:104.
    PubMed        

  3. SONG Y, Sun J, Jiang J, Xu N, et al
    Prognostic value of diffusely increased FDG uptake in spleen and/ or bone marrow due to reticuloendothelial system activation in lymphoma patients.
    BMC Cancer. 2026 Jan 17. doi: 10.1186/s12885-026-15568.
    PubMed         Abstract available


    Bone Marrow Transplant

  4. KRAMER I, Konig L, Brecht A, Hassel JC, et al
    Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma.
    Bone Marrow Transplant. 2026 Jan 20. doi: 10.1038/s41409-025-02796.
    PubMed        


    Br J Haematol

  5. YI S, Cao J, Feng R, Zhou K, et al
    A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321.
    Br J Haematol. 2026 Jan 22. doi: 10.1111/bjh.70334.
    PubMed         Abstract available

  6. ANGEL S, Marc B, Victor N, Patricia LP, et al
    Immunotherapy may be preferable to chemotherapy for patients with POD24 follicular lymphoma in the second-line setting.
    Br J Haematol. 2026 Jan 20. doi: 10.1111/bjh.70298.
    PubMed        

  7. YILDIRIM N, Anders M, Smith VM, Jayne S, et al
    The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-X(L) in DLBCL.
    Br J Haematol. 2026;208:96-105.
    PubMed         Abstract available


    Eur J Immunol

  8. PERUZZI B, Mazzoni A, Cutini I, Matani F, et al
    Downregulation of CD19 Expression Associates With Mantle Cell Lymphoma Relapse Following CAR-T Cell Therapy.
    Eur J Immunol. 2026;56:e70123.
    PubMed         Abstract available


    Int J Cancer

  9. ZUPUNSKI L, Yaumenenka A, Veyalkin I, Minenko V, et al
    Lymphoma, multiple myeloma and leukaemia incidence in regions of Belarus most heavily contaminated by the Chernobyl accident.
    Int J Cancer. 2026 Jan 23. doi: 10.1002/ijc.70346.
    PubMed         Abstract available

  10. LI D, Li N, Huang S, Zhang M, et al
    Low T3 syndrome in children with aggressive mature B-cell non-Hodgkin lymphoma.
    Int J Cancer. 2026 Jan 17. doi: 10.1002/ijc.70335.
    PubMed         Abstract available


    J Am Acad Dermatol

  11. ALLEN PB, Goyal S, Iyer S, Talluru S, et al
    Racial differences in mycosis fungoides and Sezary syndrome: A multicenter cohort study.
    J Am Acad Dermatol. 2026;94:509-516.
    PubMed         Abstract available


    J Clin Oncol

  12. CUSICK A
    Smell.
    J Clin Oncol. 2026;44:252-253.
    PubMed         Abstract available


    J Natl Cancer Inst

  13. LOWE LS, Kim DK, Rohde CH, Yu JB, et al
    Incidence of breast implant-associated anaplastic large cell lymphoma.
    J Natl Cancer Inst. 2026 Jan 22:djag019. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  14. PHILLIPS T, Zhou Z, Gutierrez C, Shao A, et al
    Real-world treatment patterns and characteristics of patients with diffuse large B-cell lymphoma (DLBCL): a retrospective analysis of US commercial and Medicare claims (2017-2024).
    Leuk Lymphoma. 2026 Jan 19:1-11. doi: 10.1080/10428194.2025.2604300.
    PubMed         Abstract available

  15. SUKE SG, Prince HM
    Epcoritamab for diffuse large B-cell lymphoma in a dialysis-dependent patient.
    Leuk Lymphoma. 2026 Jan 19:1-3. doi: 10.1080/10428194.2026.2617970.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.